Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. - Wikidata - wikimedia - TriplyDB

Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

http://www.wikidata.org/entity/Q33801290

about

Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations Transforming growth factor β signaling in uterine development and function Versican in inflammation and tissue remodeling: the impact on lung disorders The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids Associations Between TGFA/TGFB3/MSX1 Gene Polymorphisms and Congenital Non-Syndromic Hearing Impairment in a Chinese Population.Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function.An anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells.1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop.Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.Can vitamin D reduce the risk of uterine fibroids?Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.Leiomyoma-derived transforming growth factor-β impairs bone morphogenetic protein-2-mediated endometrial receptivity.The role of progesterone signaling in the pathogenesis of uterine leiomyoma Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications Dynamic reciprocity between cells and their microenvironment in reproduction.Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican.Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.Uterine fibroids and current clinical challenges.Hyaluronan, a crucial regulator of inflammation.Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop.Uterine fibroids: clinical manifestations and contemporary management.Molecular characterization of corona radiata cells from patients with diminished ovarian reserve using microarray and microfluidic-based gene expression profiling.Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/β-Catenin Signaling Pathway.Urological complications of uterine leiomyoma: a review of literature.Proteoglycans in Leiomyoma and Normal Myometrium: Abundance, Steroid Hormone Control, and Implications for Pathophysiology.The TGF-β Family in the Reproductive Tract.Quantitative proteome profiling of human myoma and myometrium tissue reveals kinase expression signatures with potential for therapeutic intervention.Dialysis-related transcriptomic profiling: the pivotal role of heparanase.Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis.Molecular and clinical attributes of uterine leiomyomas.Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.Inflammation amplification by Versican: the first mediator.

P2860

Q24567733-6E23023D-4090-472A-820B-EE2DA446E984 Q26824939-A2103DEA-5A58-4E68-BC84-01A685F12298 Q28250984-EF62ABE6-9963-4DB7-BE4F-4B1DEFFB6B11 Q29040166-34DFCFEC-E07D-46DF-8163-785CC52023CC Q30371213-C50405B5-2574-4D80-92C9-CF4C12BFA2B5 Q30379021-41E08642-2A0B-4591-A704-FCD70EF6ACC4 Q33569061-312D892D-DF94-43B0-A91A-263F1FEA2B42 Q33618778-57A7BED1-9480-4D9B-81D8-8BE7393FD2E0 Q33826120-F8948789-28A5-4DFA-AE6F-1C33372827D0 Q33995785-A06D0791-5653-47F6-9820-7427204C21F4 Q34124951-382FA518-0E0E-4D8B-A580-1FA1F8494851 Q34125151-EE96688D-C3F8-4046-A591-0CF62698ABC8 Q34125193-6C17F585-86F1-44FB-836F-3736FEFBF57E Q34223004-841E3137-3040-4718-AE18-2CC16F420BF8 Q34403426-47F6BF1B-DCCF-4760-93DB-D46715D4ED21 Q34418138-CE6B2641-37EF-4643-941C-A90E203C1D17 Q34758625-893A732A-5E24-47A5-8239-BED7C67D9141 Q35186353-7BE114B4-96B9-4007-B757-46A5BBBC2B3E Q35249360-A756DF3A-424C-4F18-8260-7C791662B3BE Q35328276-EA648C93-30A2-429C-9D02-4D0192C91FA8 Q35617092-373E154B-57ED-4E60-9A04-3427C9F3A1BB Q35795327-E9B3F705-DBA5-4800-882D-C89D83704E74 Q36198889-29BDDB79-0CD4-41A7-9F2D-AA8E3532F841 Q37109082-87B24FFE-9004-41CF-BC00-236702164E80 Q37218723-D551B0E2-3CF0-4FD4-B2D9-3EE11DCE8AD0 Q37437333-7CC1E546-B094-4051-B142-A4D7458C6784 Q37629440-077BC1CB-5B58-43F2-A146-B62073A4BDDA Q37691178-20692E13-E44E-4F60-923C-D2A0AA9266C3 Q38211241-B49A4768-FA76-4A76-AED9-39BF97888C9D Q38328666-AAD9CA71-8CD0-4CC1-9403-0987BFE3B72E Q38726268-89BF9AFF-7D71-4361-AA42-3DAE9930F704 Q38752901-D048FFFA-FF25-44C0-8FBD-DA6091A8C46A Q38831211-61441CED-FB85-4702-90DB-F795CFDE4910 Q38963328-6BA2B2ED-3A22-4688-BEA3-E895A8179061 Q39111024-1B639199-048C-412A-ACBA-6C170C8E6BE4 Q39321185-26D9673B-F7DB-49D0-BE6C-0A2802C7FA3C Q39369473-8C31C3BF-58EE-42DC-BD8A-078F03772119 Q39400414-EB2A0794-8E32-40AD-BAA0-AAD377A5FEFC Q41660259-561AF11F-0F01-469E-9EB0-3C06AA20B0F3 Q42237876-C7DDD072-2CE4-4F77-A527-35D5F9A346A5

P2860

Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

http://www.wikidata.org/entity/Q33801290

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Transforming growth factor bet ...... atrix-rich uterine leiomyomas.

@ast

Transforming growth factor bet ...... atrix-rich uterine leiomyomas.

@en

type

label

Transforming growth factor bet ...... atrix-rich uterine leiomyomas.

@ast

Transforming growth factor bet ...... atrix-rich uterine leiomyomas.

@en

prefLabel

Transforming growth factor bet ...... atrix-rich uterine leiomyomas.

@ast

Transforming growth factor bet ...... atrix-rich uterine leiomyomas.

@en

P1433

Q33801290-743F277B-2E3D-461A-A6CD-C0ED6972572B

P1476

Q33801290-60D7A70A-8E77-44C8-81DE-429989D650ED

P2093

Q33801290-1AB635CB-78F9-4621-8DDD-A9B043B01FBE

Q33801290-2E6C6313-B25E-4CB4-95CE-714A71A7B6D5

Q33801290-4450C2BE-49DA-4CE2-AAE0-E0A2DDF1024C

Q33801290-7EE8ADF0-A215-4F29-9ECC-0304310EB863

Q33801290-98A6EB6B-929F-4298-A8DA-4EB1DBD06DA2

Q33801290-98B00280-A8BB-4250-9154-01ED14D18BAE

Q33801290-EC81A521-39F0-478D-AAFB-0B72EF28E4E5

P2860

Q33801290-0E90AE2C-8B43-46E0-B762-29BB8C05E306

Q33801290-12C1CCC1-099A-498D-925F-F0E5472DEB68

Q33801290-12DD56ED-F887-437C-B88A-43400AE2D4B4

Q33801290-17081BC1-361C-44A6-BC1D-6D76A6124310

Q33801290-19E398D7-EC07-48EA-BA81-42230DD7A8C6

Q33801290-214FE144-6C74-4792-A325-5028CA1FC03B

Q33801290-215D2AF3-ACB2-4DFC-A0A9-DBFB123BE502

Q33801290-27BE7447-8EC0-46B3-ADA6-8C1A1ACD5E7D

Q33801290-2B0FE2CB-D9BA-4AB7-A16C-D64EDB361B76

Q33801290-2BB296D5-ACAB-4F1B-B0FA-68625DAB7D11

P304

Q33801290-619473F3-B840-44D1-9707-418CFD8A61B7

P31

Q33801290-E95B297A-FE56-4539-AB4E-F2B0A9E7F0A6

P356

Q33801290-79253EA0-8E80-4DDF-A0E2-7E8B603029AF

P433

Q33801290-A5785B6B-1E85-4D23-80DF-2C1BE373A663

P478

Q33801290-E7220B82-8D8A-4213-86C2-2EC1B3F563BB

P577

Q33801290-3D562AFC-F309-4BF9-A62C-2B3BFC84265F

P5875

Q33801290-C0EC6B21-7B4D-4831-BFAE-3A4E4D94ED38

P698

Q33801290-966EAEC1-E0FB-4C1A-A69F-7AF64485A8CB

P921

Q33801290-780312F7-4457-4188-9E7C-196BE8BBE381

P932

Q33801290-7580D198-C5FB-41EF-BF73-1F5DFAC0E6C9

P356

1933719109343310

P1433

Reproductive Sciences

P1476

Transforming growth factor bet ...... atrix-rich uterine leiomyomas.

@en

P2093

Candace Y Parker

http://www.w3.org/2001/XMLSchema#string

Doina Joseph

http://www.w3.org/2001/XMLSchema#string

James H Segars

http://www.w3.org/2001/XMLSchema#string

John M Norian

http://www.w3.org/2001/XMLSchema#string

Minnie Malik

http://www.w3.org/2001/XMLSchema#string

Phyllis C Leppert

http://www.w3.org/2001/XMLSchema#string

William H Catherino

http://www.w3.org/2001/XMLSchema#string

P2860

Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta

Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter

Multiple domains of the large fibroblast proteoglycan, versican

A new type of transforming growth factor-beta, TGF-beta 3

The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety

A new mathematical model for relative quantification in real-time RT-PCR

Tensional homeostasis and the malignant phenotype

The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding

Role of transforming growth factor beta in human disease

Smad regulation in TGF-beta signal transduction

P304

1153-1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1933719109343310

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26760954

http://www.w3.org/2001/XMLSchema#string

P698

19700613

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

P932

2857408

http://www.w3.org/2001/XMLSchema#string